Abeona Therapeutics Inc (ABEO)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vishwas Seshadri
Employees:
90
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
646-813-4701
-
Formally known as:
- Access Pharmaceuticals Inc
- Access Pharmaceuticals Inc.
- PLASMATECH BIOPHARMACEUTICALS,
Date | Ratio |
---|---|
2006-06-05 | 0.2000 |
2014-10-24 | 1:50 |
2022-07-05 | 1:25 |
Abeona Therapeutics Inc. develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|